long term glp 1 studies In recent years, GLP-1 medications have transformed obesity treatment, producing unprecedented amounts of weight loss in clinical trials. But they come with an important challenge... What happens when people stop taking them? Long-term Success of GLP-1s Hinges

Description

65% Polyester, 35% Cotton

95% CI 0.750.98, p=0.03), Dulaglutide (RR 0.82, 95% CI 0.700.96, p=0.02), Albiglutide (RR 0.93,95% CI 0.791.10, p=0.40), Exenatide (RR 0.93, 95% CI 0.741.18, p=0.55), Lixisenatide (RR 0.83, 95% CI 0.621.12, p=0.22), and Efpeglenatide (RR 0.76, 95% CI 0.461.24, p=0.27)

See what research says about maintenance.

Discontinuation of GLP-1 receptor agonists before pregnancy or early during pregnancy was tied to more gestational weight and a higher risk for some adverse health outcomes, a study in JAMA Women’s Health showed.The data “suggest that people on GLP-1s discontinuing the medication for pregnancy require closer monitoring for excess weight gain and complications,&rdquo